Brokers Offer Predictions for ICON Public FY2024 Earnings

ICON Public Limited (NASDAQ:ICLR - Free Report) - Equities research analysts at William Blair raised their FY2024 earnings per share (EPS) estimates for shares of ICON Public in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the medical research company will post earnings of $13.55 per share for the year, up from their prior estimate of $13.40. William Blair currently has a "Outperform" rating on the stock. The consensus estimate for ICON Public's current full-year earnings is $13.41 per share. William Blair also issued estimates for ICON Public's FY2025 earnings at $13.33 EPS.

A number of other equities analysts have also recently commented on ICLR. Barclays cut their price target on shares of ICON Public from $330.00 to $275.00 and set an "overweight" rating for the company in a research note on Friday, October 25th. JPMorgan Chase & Co. cut their target price on ICON Public from $375.00 to $280.00 and set an "overweight" rating for the company in a research note on Friday, October 25th. Robert W. Baird decreased their price target on shares of ICON Public from $249.00 to $225.00 and set a "neutral" rating on the stock in a research note on Wednesday, November 20th. Leerink Partners reaffirmed an "outperform" rating and issued a $255.00 price objective (down previously from $270.00) on shares of ICON Public in a research note on Tuesday, November 19th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $263.00 target price on shares of ICON Public in a report on Wednesday, January 15th. Four investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $287.00.

ICON Public Price Performance

Shares of ICLR traded down $4.36 during trading hours on Monday, reaching $198.11. 1,229,570 shares of the company's stock traded hands, compared to its average volume of 679,048. ICON Public has a 12 month low of $183.38 and a 12 month high of $347.72. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 0.35. The stock has a market cap of $16.34 billion, a PE ratio of 22.09, a price-to-earnings-growth ratio of 1.59 and a beta of 1.20. The firm's 50 day simple moving average is $209.71 and its 200-day simple moving average is $267.52.

ICON Public (NASDAQ:ICLR - Get Free Report) last posted its earnings results on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.72 by ($0.37). The firm had revenue of $2.03 billion during the quarter, compared to analysts' expectations of $2.13 billion. ICON Public had a return on equity of 11.91% and a net margin of 9.00%. The business's revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.10 earnings per share.

Institutional Investors Weigh In On ICON Public

Several institutional investors and hedge funds have recently modified their holdings of ICLR. Park Place Capital Corp grew its stake in ICON Public by 281.4% in the fourth quarter. Park Place Capital Corp now owns 225 shares of the medical research company's stock worth $47,000 after purchasing an additional 166 shares during the period. GAMMA Investing LLC grew its position in shares of ICON Public by 64.0% in the 4th quarter. GAMMA Investing LLC now owns 433 shares of the medical research company's stock worth $91,000 after buying an additional 169 shares during the period. EverSource Wealth Advisors LLC lifted its position in ICON Public by 39.2% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 394 shares of the medical research company's stock valued at $129,000 after acquiring an additional 111 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its position in ICON Public by 23.1% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 511 shares of the medical research company's stock valued at $147,000 after acquiring an additional 96 shares during the period. Finally, First Horizon Advisors Inc. grew its holdings in ICON Public by 33.9% in the third quarter. First Horizon Advisors Inc. now owns 597 shares of the medical research company's stock worth $172,000 after purchasing an additional 151 shares during the period. 95.61% of the stock is owned by hedge funds and other institutional investors.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.